B
Bartlett C. Hamilton
Researcher at University of Nebraska Medical Center
Publications - 7
Citations - 416
Bartlett C. Hamilton is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Rheumatoid arthritis & Internal medicine. The author has an hindex of 3, co-authored 5 publications receiving 350 citations. Previous affiliations of Bartlett C. Hamilton include United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
Ted R. Mikuls,Jeffrey B. Payne,Fang Yu,Geoffrey M. Thiele,Richard J. Reynolds,Grant W. Cannon,Jeffrey Markt,David McGowan,Gail S. Kerr,Robert S. Redman,Andreas M. Reimold,Garth R. Griffiths,Mark W. Beatty,Shawneen M. Gonzalez,Debra A. Bergman,Bartlett C. Hamilton,Alan R Erickson,Jeremy Sokolove,William H. Robinson,Clay Walker,Fatiha Chandad,James R. O'Dell +21 more
TL;DR: To examine the degree to which shared risk factors explain the relationship of periodontitis to rheumatoid arthritis (RA) and to determine the associations of PD and Porphyromonas gingivalis with pathologic and clinical features of RA.
Journal ArticleDOI
Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins.
Michael J. Duryee,Michael J. Duryee,Thomas L. Freeman,Thomas L. Freeman,Monte S. Willis,Carlos D. Hunter,Carlos D. Hunter,Bartlett C. Hamilton,Bartlett C. Hamilton,Hiroshi Suzuki,Hiroshi Suzuki,Dean J. Tuma,Lynell Warren Klassen,Geoffrey M. Thiele +13 more
TL;DR: RT-PCR data show the presence of a number of scavenger receptors on SECs that may be responsible for the binding of MAA-modified proteins, and SRA seems to be one of these receptors involved in the effects mediated by MAA -modified proteins.
Journal ArticleDOI
Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis
Joshua F. Baker,Bryant R. England,Michael D. George,Grant W. Cannon,Brian C. Sauer,Alexis Ogdie,Bartlett C. Hamilton,Carlos D. Hunter,Michael J. Duryee,Geoffrey M. Thiele,Ted R. Mikuls +10 more
TL;DR: In this paper, the authors determined associations between inflammatory disease activity (including evaluation of specific cytokines and chemokines) and incident diabetes mellitus (DM) using multivariable Cox proportional hazard models.
Journal ArticleDOI
Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis
L. Federico,Tate M. Johnson,Bryant R. England,Katherine D Wysham,Michael D. George,Brian C. Sauer,Bartlett C. Hamilton,Carlos D. Hunter,Michael J. Duryee,Geoffrey M. Thiele,Ted R. Mikuls,Joshua F. Baker +11 more
TL;DR: It is suggested that adipokines effectively predict clinically important outcomes in RA perhaps through an association with body composition and metabolic health.
Journal ArticleDOI
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Yun-Jeong Song,In Ah Choi,Françoise Meylan,M. Kristen Demoruelle,Taylor K. Farley,Arianne C. Richard,Eric T. Hawley,John Botson,Yoo Jin Hong,Eun Young Lee,Sabina R. Mian,Bartlett C. Hamilton,Geoffrey M. Thiele,Ted R. Mikuls,Naveen Gara,Christopher D. Ward,S. Lamberth,Kevin D. Deane,Theo Heller,Michael M. Ward,David M. Lee,David M. Lee,Thi-Sau Migone,William Stohl,James R. O'Dell,Jill M. Norris,V. Michael Holers,Peter K. Gregersen,Yeong Wook Song,Richard M. Siegel +29 more
TL;DR: The decline in TL1A after TNF blockade suggests thatTL1A levels may be a useful biomarker for TNF activity in RA, and these results support the further investigation of the relationship between TL 1A and TNF and TL1a blockade as a potential therapeutic strategy in RA.